Oct 08, 2018
Salix to Present Clinical Data for XIFAXAN® (RIFAXIMIN) and PLENVU® at the American College of Gastroenterology Annual Meeting
Sep 28, 2018
Salix Resolves Legacy SEC Investigation With No Penalty
Sep 12, 2018
Bausch Health Announces Resolution Of XIFAXAN® Intellectual Property Litigation
Sep 11, 2018
Salix Announces U.S. Launch of PLENVU®, the First and Only 1-Liter PEG Bowel Cleansing Preparation for Colonoscopies
Sep 06, 2018
Salix Pharmaceuticals To Present Clinical Data For The Treatment Of Opioid-Induced Constipation At 2018 PAINWeek Conference
Sep 04, 2018
US WorldMeds And Salix Pharmaceuticals To Highlight Clinical Data For Opioid Withdrawal Treatment LUCEMYRA(TM) (lofexidine) At 2018 PAINWeek Conference
Aug 06, 2018
US WorldMeds and Salix Announce U.S. Launch of LUCEMYRA(TM) (lofexidine) 0.18 Mg Tablets
Aug 03, 2018
Salix Expands Microbiome Research And Discovery Through Strategic Collaboration With Cedars-Sinai Medical Center
Jun 26, 2018
Salix And US WorldMeds Enter Into Exclusive Co-Promotion Agreement For Opioid Withdrawal Treatment LUCEMYRA(TM) (lofexidine)
Jun 05, 2018
Salix And Its Partner Norgine Present New Data From PLENVU® (NER1006) Phase 3 Studies At Digestive Disease Week (DDW) 2018
Jun 04, 2018
RDD Pharma Appoints Dr. Mark Sirgo as Board Chairman
Jun 03, 2018
Salix Presents Positive Phase 3 Investigational Study Data For Repeat Rifaximin Treatment In Patients With Diarrhea Predominant Irritable Bowel Syndrome
Jun 03, 2018
Salix Presents Rifaximin Phase 3 Study Results for Irritable Bowel Syndrome with Diarrhea at Digestive Disease Week
May 31, 2018
Salix To Highlight New Clinical Data During Digestive Disease Week
May 07, 2018
Salix Receives FDA Approval For PLENVU®, Next Generation 1-Liter Bowel Cleansing Preparation For Colonoscopies
May 02, 2018
Summary Judgment Granted Upholding The Validity Of Formulation Patent Protecting RELISTOR® Injection
Apr 24, 2018
Argentum and Cosmo Settle Patent Dispute Over UCERIS®
Apr 03, 2018
Salix Launches 'Let's Talk 2' IBS Awareness Campaign
Feb 09, 2018
Salix Provides Update on FDA Submission for PLENVU®*
Sep 05, 2017
Salix Announces Four Poster Presentations, Two Product Theatres At PAINWeek 2017